Zanite Acquisition Corp. (ZNTEU)
Price:
11.53 USD
( + 1.52 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Agriculture & Natural Solutions Acquisition Corporation
VALUE SCORE:
6
2nd position
Drugs Made In America Acquisition Corp. Ordinary Shares
VALUE SCORE:
11
The best
Drugs Made In America Acquisition Corp. Rights
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Zanite Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the aviation, aerospace and defense, urban mobility, and emerging technology industries. The company was incorporated in 2020 and is based in Cleveland, Ohio.
NEWS
Zanite Acquisition Corp. Confirms Negotiations with Eve Urban Air Mobility Solutions, Inc.
businesswire.com
2021-06-10 18:01:00CLEVELAND--(BUSINESS WIRE)-- #SPAC--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (“Zanite” or the “Company”) today confirmed that it is in negotiations relating to a potential business combination with Eve Urban Air Mobility Solutions, Inc., a subsidiary of Embraer S.A., a Brazilian corporation. There can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated. About Zanite Acquisition Corp. Zanite is a blank check company, also commonly referre
Zanite Acquisition Corp. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
businesswire.com
2021-05-28 18:36:00CLEVELAND--(BUSINESS WIRE)-- #Ricci--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (the “Company”) today announced that it received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Q1 2021 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on or b
Zanite Acquisition Corp. Announces Sponsor's Intention to Purchase Private Placement Warrants to Extend Completion Window to November 19, 2021
businesswire.com
2021-05-13 16:07:00CLEVELAND--(BUSINESS WIRE)-- #SPAC--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (the “Company”) announced today that it has received notice from Zanite Sponsor LLC (the “Sponsor”) of its intention to purchase an additional 2,300,000 private placement warrants (the “Private Placement Warrants”) to extend the period of time the Company will have to consummate its initial business combination by 6 months from the current deadline of May 19, 2021 until November 19, 2021 (the “completion window”). Pursuant to
Zanite Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or about January 7, 2021
businesswire.com
2020-12-29 16:08:00CLEVELAND--(BUSINESS WIRE)-- #KennRicci--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (the “Company”) announced today that holders of the units sold in the Company's initial public offering of 23,000,000 units completed on November 19, 2020 may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about January 7, 2021. Any units not separated will continue to trade on The Nasdaq Capital Market under the symbol “ZNTEU,” and each of the shares of Class A
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.
No data to display
Zanite Acquisition Corp. Confirms Negotiations with Eve Urban Air Mobility Solutions, Inc.
businesswire.com
2021-06-10 18:01:00CLEVELAND--(BUSINESS WIRE)-- #SPAC--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (“Zanite” or the “Company”) today confirmed that it is in negotiations relating to a potential business combination with Eve Urban Air Mobility Solutions, Inc., a subsidiary of Embraer S.A., a Brazilian corporation. There can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated. About Zanite Acquisition Corp. Zanite is a blank check company, also commonly referre
Zanite Acquisition Corp. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
businesswire.com
2021-05-28 18:36:00CLEVELAND--(BUSINESS WIRE)-- #Ricci--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (the “Company”) today announced that it received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Q1 2021 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on or b
Zanite Acquisition Corp. Announces Sponsor's Intention to Purchase Private Placement Warrants to Extend Completion Window to November 19, 2021
businesswire.com
2021-05-13 16:07:00CLEVELAND--(BUSINESS WIRE)-- #SPAC--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (the “Company”) announced today that it has received notice from Zanite Sponsor LLC (the “Sponsor”) of its intention to purchase an additional 2,300,000 private placement warrants (the “Private Placement Warrants”) to extend the period of time the Company will have to consummate its initial business combination by 6 months from the current deadline of May 19, 2021 until November 19, 2021 (the “completion window”). Pursuant to
Zanite Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or about January 7, 2021
businesswire.com
2020-12-29 16:08:00CLEVELAND--(BUSINESS WIRE)-- #KennRicci--Zanite Acquisition Corp. (Nasdaq: ZNTEU) (the “Company”) announced today that holders of the units sold in the Company's initial public offering of 23,000,000 units completed on November 19, 2020 may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about January 7, 2021. Any units not separated will continue to trade on The Nasdaq Capital Market under the symbol “ZNTEU,” and each of the shares of Class A
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.